Academic Journal
Quartile not availableMolecular Therapy: Oncolytics
About Molecular Therapy: Oncolytics
Molecular Therapy: Oncolytics is listed in the JournalsWorld journal directory. Its recorded ISSN identifier(s): 2372-7705.
Journal Metrics
A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Molecular Therapy Oncology: What’s in a name?
Timothy P. Cripe
2023-12 · DOI: 10.1016/j.omto.2023.100739Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancer
Jessica A. Minott, Jacob P. van Vloten, Jake G.E. Yates, Lisa A. Santry et al.
2023-12 · DOI: 10.1016/j.omto.2023.100748Dual blockade of CD47 and CD24 signaling using a novel bispecific antibody fusion protein enhances macrophage immunotherapy
Yun Yang, He Wu, Yan Yang, Yan Kang et al.
2023-12 · DOI: 10.1016/j.omto.2023.100747New advances in cancer therapy targeting TGF-β signaling pathways
Minyue Shou, Hanyu Zhou, Ling Ma
2023-12 · DOI: 10.1016/j.omto.2023.100755Beyond ENO1, emerging roles and targeting strategies of other enolases in cancers
Jiaojiao Ni, Yihui Huang, Chaoqun Li, Qian Yin et al.
2023-12 · DOI: 10.1016/j.omto.2023.100750Replication-incompetent influenza A viruses armed with IFN-γ effectively mediate immune modulation and tumor destruction in mice harboring lung cancer
Ramona Meissner, Viktor Wixler, Franziska Paulina Wulfert, Jasmin Carina Jacob et al.
2023-12 · DOI: 10.1016/j.omto.2023.100741Preclinical assessment of a novel human antibody VH domain targeting mesothelin as an antibody-drug conjugate
Zehua Sun, Xiaojie Chu, Cynthia Adams, Tatiana V. Ilina et al.
2023-12 · DOI: 10.1016/j.omto.2023.09.002Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers
Thanyavi Chinsuwan, Koichi Hirabayashi, Shuji Mishima, Aiko Hasegawa et al.
2023-12 · DOI: 10.1016/j.omto.2023.100728Peritoneal-directed chimeric oncolytic virus CF17 prevents malignant ascites and improves survival in gastric cancer peritoneal metastases
Annie Yang, Zhifang Zhang, Shyambabu Chaurasiya, Anthony K. Park et al.
2023-12 · DOI: 10.1016/j.omto.2023.100734Treatment with the PPARα agonist fenofibrate improves the efficacy of CD8+ T cell therapy for melanoma
Mohadeseh Hasanpourghadi, Arezki Chekaoui, Sophia Kurian, Raj Kurupati et al.
2023-12 · DOI: 10.1016/j.omto.2023.100744Breaking the barriers in cancer care: The next generation of herpes simplex virus-based oncolytic immunotherapies for cancer treatment
Nikhil I. Khushalani, Kevin J. Harrington, Alan Melcher, Praveen K. Bommareddy et al.
2023-12 · DOI: 10.1016/j.omto.2023.100729miR-146a: Overcoming coldness in ovarian cancer
Yanqi Ye, Nanhai G. Chen
2023-12 · DOI: 10.1016/j.omto.2023.100753Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcoma
Kelly M. Makielski, Aaron L. Sarver, Michael S. Henson, Kathleen M. Stuebner et al.
2023-12 · DOI: 10.1016/j.omto.2023.100736Targeting the lactic acid metabolic pathway for antitumor therapy
Zhi Li, Jiuwei Cui
2023-12 · DOI: 10.1016/j.omto.2023.100740The role and application of vesicles in triple-negative breast cancer: Opportunities and challenges
Ya-Nan Wei, Chun-Yan Yan, Meng-Lu Zhao, Xi-He Zhao et al.
2023-12 · DOI: 10.1016/j.omto.2023.100752Pre-treatment with systemic agents for advanced NSCLC elicits changes in the phenotype of autologous T cell therapy products
Charlotte O’Brien Gore, Amy Billman, Suchete Hunjan, Jayne Colebrook et al.
2023-12 · DOI: 10.1016/j.omto.2023.100749CM082 Enhances the Efficacy of Chemotherapeutic Drugs by Inhibiting the Drug Efflux Function of ABCG2
Lejia Xu, Jiwei Huang, Jie Liu, Yun Xi et al.
2023-12 · DOI: 10.1016/j.omto.2023.100746Targeting mesothelin in cancer
Cem Elbi
2023-12 · DOI: 10.1016/j.omto.2023.100756An epitope encoded by uORF of RNF10 elicits a therapeutic anti-tumor immune response
Lili Zeng, Wei Zheng, Jiahui Zhang, Jiawen Wang et al.
2023-12 · DOI: 10.1016/j.omto.2023.100737Retraction Notice to: miR-140-3p Inhibits Cutaneous Melanoma Progression by Disrupting AKT/p70S6K and JNK Pathways through ABHD2
Yuanmin He, Yan Yang, Yongmei Liao, Jixiang Xu et al.
2023-12 · DOI: 10.1016/j.omto.2023.100742Reviews
Community Reviews
Version History
October 13, 2026 at 9:58 am
October 13, 2026